122 related articles for article (PubMed ID: 7878477)
1. Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma.
Klein B
Semin Hematol; 1995 Jan; 32(1):4-19. PubMed ID: 7878477
[No Abstract] [Full Text] [Related]
2. Role of INTERLEUKIN-6 in the pathogenesis of multiple myeloma.
Gadó K; Domján G; Hegyesi H; Falus A
Cell Biol Int; 2000; 24(4):195-209. PubMed ID: 10816321
[TBL] [Abstract][Full Text] [Related]
3. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily.
Hirano T; Matsuda T; Nakajima K
Stem Cells; 1994 May; 12(3):262-77. PubMed ID: 8075593
[TBL] [Abstract][Full Text] [Related]
4. Constitutive expression of IL-6-LIKE cytokines in normal bone marrow: implications for pathophysiology of myeloma.
Barton BE; Murphy TF
Cytokine; 2000 Oct; 12(10):1537-45. PubMed ID: 11023670
[TBL] [Abstract][Full Text] [Related]
5. Regulation of interleukin 6 in multiple myeloma and bone marrow stromal cells.
Chauhan D; Uchiyama H; Urashima M; Yamamoto K; Anderson KC
Stem Cells; 1995 Aug; 13 Suppl 2():35-9. PubMed ID: 8520509
[TBL] [Abstract][Full Text] [Related]
6. Signalling and survival pathways in multiple myeloma.
Bommert K; Bargou RC; Stühmer T
Eur J Cancer; 2006 Jul; 42(11):1574-80. PubMed ID: 16797970
[TBL] [Abstract][Full Text] [Related]
7. [Study of IL-6 signal transduction pathway in a human multiple myeloma cell line--Sko-007].
Song L; Li Y; Shen B
Zhonghua Xue Ye Xue Za Zhi; 2000 Nov; 21(11):569-71. PubMed ID: 11225245
[TBL] [Abstract][Full Text] [Related]
8. [Signal transduction and biological function of IL-6 in a human myeloma cell line-XG-7].
Song L; Shen B
Zhonghua Yi Xue Za Zhi; 2000 Nov; 80(11):845-8. PubMed ID: 11218881
[TBL] [Abstract][Full Text] [Related]
9. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
Giuliani N; Colla S; Morandi F; Rizzoli V
Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473
[TBL] [Abstract][Full Text] [Related]
10. GP130 cytokines, interferon, survival and proliferation of human myeloma cells.
Klein B
Eur Cytokine Netw; 1997 Sep; 8(3):323. PubMed ID: 9346376
[No Abstract] [Full Text] [Related]
11. Interleukin-6 in multiple myeloma and related plasma cell dyscrasias.
Treon SP; Anderson KC
Curr Opin Hematol; 1998 Jan; 5(1):42-8. PubMed ID: 9515202
[TBL] [Abstract][Full Text] [Related]
12. Expression and production of interleukin 10 in human myeloma cell lines.
Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A
Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145
[TBL] [Abstract][Full Text] [Related]
13. Etiology of multiple myeloma: what's new.
Berenson JR
Semin Oncol; 1999 Oct; 26(5 Suppl 13):2-9. PubMed ID: 10528889
[TBL] [Abstract][Full Text] [Related]
14. [gp-130 related cytokines in mechanisms of myeloma cell growth].
Fukutoku M; Shimizu S
Rinsho Ketsueki; 1997 Apr; 38(4):262-5. PubMed ID: 9146047
[No Abstract] [Full Text] [Related]
15. [Mutual interaction between myeloma cells and bone marrow microenvironment].
Abe M
Rinsho Ketsueki; 2009 Jun; 50(6):453-60. PubMed ID: 19571504
[No Abstract] [Full Text] [Related]
16. Activating mutations in the N- and K-ras oncogenes differentially affect the growth properties of the IL-6-dependent myeloma cell line ANBL6.
Billadeau D; Liu P; Jelinek D; Shah N; LeBien TW; Van Ness B
Cancer Res; 1997 Jun; 57(11):2268-75. PubMed ID: 9187131
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ
Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780
[TBL] [Abstract][Full Text] [Related]
18. [Human plasmacytoma from biology to clinical practice].
Bataille R; Klein B
Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):179-82. PubMed ID: 8337119
[No Abstract] [Full Text] [Related]
19. Myeloma biology and therapy. Present status and future developments.
Nishimoto N; Shima Y; Yoshizaki K; Kishimoto T
Hematol Oncol Clin North Am; 1997 Feb; 11(1):159-72. PubMed ID: 9081210
[TBL] [Abstract][Full Text] [Related]
20. Cytokines and signal transduction.
Hideshima T; Podar K; Chauhan D; Anderson KC
Best Pract Res Clin Haematol; 2005; 18(4):509-24. PubMed ID: 16026734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]